1. Home
  2. TOVX vs NXTT Comparison

TOVX vs NXTT Comparison

Compare TOVX & NXTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOVX
  • NXTT
  • Stock Information
  • Founded
  • TOVX 2001
  • NXTT 2019
  • Country
  • TOVX United States
  • NXTT China
  • Employees
  • TOVX N/A
  • NXTT N/A
  • Industry
  • TOVX Biotechnology: Pharmaceutical Preparations
  • NXTT
  • Sector
  • TOVX Health Care
  • NXTT
  • Exchange
  • TOVX Nasdaq
  • NXTT NYSE
  • Market Cap
  • TOVX 4.0M
  • NXTT 3.5M
  • IPO Year
  • TOVX 2006
  • NXTT N/A
  • Fundamental
  • Price
  • TOVX $1.41
  • NXTT $0.30
  • Analyst Decision
  • TOVX Strong Buy
  • NXTT
  • Analyst Count
  • TOVX 1
  • NXTT 0
  • Target Price
  • TOVX $6.00
  • NXTT N/A
  • AVG Volume (30 Days)
  • TOVX 21.6K
  • NXTT 70.7K
  • Earning Date
  • TOVX 05-06-2025
  • NXTT 05-19-2025
  • Dividend Yield
  • TOVX N/A
  • NXTT N/A
  • EPS Growth
  • TOVX N/A
  • NXTT N/A
  • EPS
  • TOVX N/A
  • NXTT 3.73
  • Revenue
  • TOVX N/A
  • NXTT $1,800,000.00
  • Revenue This Year
  • TOVX N/A
  • NXTT N/A
  • Revenue Next Year
  • TOVX N/A
  • NXTT N/A
  • P/E Ratio
  • TOVX N/A
  • NXTT $0.08
  • Revenue Growth
  • TOVX N/A
  • NXTT N/A
  • 52 Week Low
  • TOVX $0.96
  • NXTT $0.22
  • 52 Week High
  • TOVX $12.25
  • NXTT $6.00
  • Technical
  • Relative Strength Index (RSI)
  • TOVX 58.99
  • NXTT 40.56
  • Support Level
  • TOVX $1.28
  • NXTT $0.25
  • Resistance Level
  • TOVX $1.47
  • NXTT $0.29
  • Average True Range (ATR)
  • TOVX 0.13
  • NXTT 0.03
  • MACD
  • TOVX 0.03
  • NXTT 0.03
  • Stochastic Oscillator
  • TOVX 87.13
  • NXTT 92.13

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

About NXTT NEXT TECHNOLOGY HOLDING INC

Next Technology Holding Inc pursues two corporate strategies. One business strategy is to continue providing software development services, and the other strategy is to acquire and hold Bitcoin. It provides AI-enabled software development services to its customers, which include developing, designing, and implementing various SAAS software solutions for businesses of all types, including industrial and other businesses. Its bitcoin acquisition strategy generally involves acquiring bitcoin with its liquid assets that exceed working capital requirements, and from time to time, subject to market conditions, issuing debt or equity securities or engaging in other capital raising transactions to use the proceeds to purchase bitcoin.

Share on Social Networks: